Rapid assessment of early biophysical changes in K562 cells during apoptosis determined using dielectrophoresis

Sue Chin1, Michael P Hughes, Helen M Coley

  • 1Centre for Biomedical Engineering, School of Engineering, University of Surrey, Guildford, Surrey, UK.

Insights

Early cancer detection is crucial for drug discovery. This study uses dielectrophoresis to rapidly detect apoptosis (programmed cell death) in cancer cells, offering a faster method than traditional approaches.

Area of Science:

  • Cell Biology
  • Biophysics
  • Cancer Research

Background:

  • Apoptosis, or programmed cell death, is a critical cellular process.
  • Dysregulation of apoptosis is frequently implicated in cancer development.
  • Early detection of apoptosis is essential for developing novel anti-cancer therapeutics.

Purpose of the Study:

  • To introduce dielectrophoresis as a novel method for the rapid detection of early-stage apoptosis.
  • To investigate the changes in electrophysiological properties during apoptosis induction.

Main Methods:

  • Utilizing dielectrophoresis, an electrical phenomenon, to monitor cellular changes.
  • Measuring cytoplasmic conductivity in K562 human myelogenous leukemia cells.
  • Inducing apoptosis using staurosporine.

Main Results:

  • Dielectrophoresis detected significant changes in electrophysiological properties indicative of apoptosis.
  • A persistent elevation in cytoplasmic conductivity was observed as early as 30 minutes post-staurosporine exposure in K562 cells.
  • This early detection is significantly faster than conventional biochemical marker methods.

Conclusions:

  • Dielectrophoresis provides a rapid and sensitive method for detecting early-stage apoptosis.
  • This technique has potential applications in accelerating anti-cancer drug discovery.
  • Electrophysiological property changes serve as reliable early biomarkers for apoptosis.

Related Concept Videos